A New Trend of Digital Healthcare in 3D Printed Medicines

Itimad Raheem Ali, Jwan K. Alwan, Dhulfiqar Saad Jaafar and Hoshang Kolivand

Computer and Information Science, 2020, vol. 13, issue 4, 12

Abstract: Three-dimensional ‎(‎3D) technique of restricting scrambling is changing the ways of drug design, labeling and ‎production in the area of ‎digital health. By combining digital and genetic techniques, Fused ‎Deposition Modeling (FDM) can manufacture ‎normalization systems. Consecutively, such a ‎method can allow for speedy improvements in the healthcare ‎systems, allowing the allocation ‎of medicines based on patient’s needs and requirements. So far, several 3D ‎based medicinal ‎goods have been marketed. These include the production of implants and several useful related ‎‎products for use in medical applications. Nevertheless, regulatory obstacles remain with ‎developing medicines. ‎This article reviews the latest FDM technology in medical and ‎pharmaceutical research, including a discussion of ‎the potential challenges in the field. ‎Emphasis has been paid on future developments needed for facilitating the ‎FDM integration ‎into dispensaries and clinics.‎

Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.ccsenet.org/journal/index.php/cis/article/download/0/0/43850/46099 (application/pdf)
http://www.ccsenet.org/journal/index.php/cis/article/view/0/43850 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ibn:cisjnl:v:13:y:2020:i:4:p:12

Access Statistics for this article

More articles in Computer and Information Science from Canadian Center of Science and Education Contact information at EDIRC.
Bibliographic data for series maintained by Canadian Center of Science and Education ().